Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
rivaroxaban
rivaroxaban
Brand names: Xarelto
| Form | Strength |
|---|---|
| TABLET, ORAL | 10 mg; 15 mg |
Last updated: Jan. 17, 2022
- High Alert: CAUTION: See High-Alert Medication Policy
- Black Box Warning: Premature discontinuation; spinal/epidural hematomas
rivaroxaban
Anticoagulation Therapy Management: Policy 900.3207
Clinical Guidelines:
Initiation/Dosing: Anticoagulation selection for patients with non-valvular atrial fibrillation. See Guideline 900.5008
Initiation/Other: Direct Oral Anticoagulant Use for Venous Thromboembolism, see Protocol 900.5206
Transitioning: Warfarin transition (to or from rivaroxaban): See Guideline 900.5863
Surgery: Timing of Neuraxial Anesthesia and Anticoagulation: see Guideline 900.5683
Surgery: Periprocedural Management of Anticoagulation therapy: See Protocol 900.5011
Reversal: Reversal in bleeding patients or for emergent surgery: See Reversal Guideline 900.5010
Antithrombotic and Anticoagulant Treatment in Stroke: See 900.5018